Comments and Letters

  • Letter to CMS Regarding Saturation Biopsy

    December 10, 2011
        December 10, 2011   Mr. Marc Hartstein, Acting Director Hospital and Ambulatory Policy Group Center for Medicare Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244   Dear Mr. Hartstein:   On behalf of the American Clinical Laboratory Association (“ACLA”), I am writing to express our concerns about CMS’s recent actions with respect to HCPCS code G0416, which isContinue Reading »...
  • Letter to Chairman Baucus and Ranking Member Hatch Regarding TC “Grandfather” Provision

    December 07, 2011
        December 7, 2011   The Honorable Max Baucus Chairman Senate Finance Committee Washington, DC 20510   The Honorable Orrin Hatch Ranking Member Senate Finance Committee Washington, DC 20510   Dear Chairman Baucus and Ranking Member Hatch:   The undersigned organizations, representing laboratories, hospitals, laboratory professionals, physicians, and the patients we serve, urge you to extend an expiring provision that would ensure hospitalsContinue Reading »...
  • Letter to Chairman Camp and Ranking Member Levin Regarding TC “Grandfather” Provision

    December 07, 2011
      December 7, 2011 The Honorable Dave Camp Chairman House Committee on Ways and Means Washington, DC 20515 The Honorable Sandy Levin Ranking Member House Committee on Ways and Means Washington, DC 20515 Dear Chairman Camp and Ranking Member Levin: The undersigned organizations, representing laboratories, hospitals, laboratory professionals, physicians, and the patients we serve, urge you to extend an expiring provision that would ensureContinue Reading »...
  • Letter to Majority Leader Reid and Minority Leader McConnell Regarding SGR

    December 05, 2011
      December 5, 2011   The Honorable Harry Reid Majority Leader U.S. Senate Washington, D.C. 20510   The Honorable Mitch McConnell Minority Leader U.S. Senate Washington, D.C. 20510   Dear Majority Leader Reid and Minority Leader McConnell:   The Alliance for Integrity in Medicare (AIM), a coalition committed to ending the practice of inappropri- ate physician self-referral in Medicare, appreciates your commitment to addressContinue Reading »...
  • Letter to Chairman Upton and Ranking Member Waxman Regarding SGR

    December 05, 2011
        December 5, 2011   The Honorable Fred Upton Chairman Committee on Energy and Commerce U.S. House of Representatives Washington, D.C. 20515   The Honorable Henry Waxman Ranking Member Committee on Energy and Commerce U.S. House of Representatives Washington, D.C. 20515   Dear Chairman Upton and Ranking Member Waxman:   The Alliance for Integrity in Medicare (AIM), a coalition committed to ending theContinue Reading »...
  • Letter to Chairman Baucus and Ranking Member Hatch Regarding SGR

    December 05, 2011
    See the original PDF here. December 5, 2011   The Honorable Max Baucus Chairman, Committee on Finance U.S. Senate Washington, D.C. 20510   The Honorable Orrin Hatch Ranking Member, Committee on Finance U.S. Senate Washington, D.C. 20510   Dear Chairman Baucus and Ranking Member Hatch:   The Alliance for Integrity in Medicare (AIM), a coalition committed to ending the practice of inappropri- ate physicianContinue Reading »...
  • Letter to Chairman Camp and Ranking Member Levin Regarding SGR

    December 03, 2011
        December 5, 2011   The Honorable Dave Camp Chairman Committee on Ways and Means U.S. House of Representatives Washington, D.C. 20515   The Honorable Sander Levin Ranking Member Committee on Ways and Means U.S. House of Representatives Washington, D.C. 20515   Dear Chairman Camp and Ranking Member Levin:   The Alliance for Integrity in Medicare (AIM), a coalition committed to ending theContinue Reading »...
  • Comment Letter on Palmetto LCD for Molecular Diagnostic Tests

    December 02, 2011
        December 2, 2011   Dr. Elaine Jeter, Medical Director Mr. Michael Barlow, Vice President Palmetto GBA (J1 MAC) P.O. Box 100190, AG 300 Columbia, South Carolina 29202-3190   RE: Palmetto GBA Draft Local Coverage Determination (LCD) for Molecular Diagnostic Tests (MDT) (DL 32288)   Dear Dr. Jeter and Mr. Barlow:   The American Clinical Laboratory Association (“ACLA”) hereby submits comments on PalmettoContinue Reading »...
  • Comments on HHS Proposed Rule on Patient Access to Test Results

    November 14, 2011
      November 14, 2011   Centers for Medicare & Medicaid Services Department of Health and Human Services Room 445-G Hubert H. Humphrey Building 200 Independence Avenue S.W. Washington, DC 20201   RE:      BIN 0938-AQ38; CLIA Program and HIPAA Privacy Rule; Patients’ Access to Test Reports; Proposed Rule Dear Sir or Madam,   The American Clinical Laboratory Association (“ACLA”) appreciates the opportunity to comment onContinue Reading »...
  • Letter On Implementation of Meaningful Use 2 and re-implementation of Meaningful Use 3

    October 31, 2011
    October 31, 2011   Farzad Mostashari, MD, ScM Office of the National Coordinator for Health Information Technology U.S. Department of Health and Human Services 200 Independence Avenue S.W. Suite 729-D Washington, D.C. 20201   RE: Implementation of Meaningful Use 2 and re-implementation of Meaningful Use 3   Dear Dr. Mostashari,   The American Clinical Laboratory Association (ACLA) is an association representing clinical laboratories throughout theContinue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18